Page 1 of Clinical Trials for fulvestrant, 98 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer
Last Updated: March 8, 2010
Condition(s): Carcinoma, Non Small Cell Lung
2
Active, not recruiting
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
Last Updated: April 30, 2012
Condition(s): Advanced Breast Cancer
3
Active, not recruiting
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Last Updated: September 12, 2011
Condition(s): Metastatic Breast Cancer
4
Completed
Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Last Updated: June 11, 2008
Condition(s): Breast Cancer
5
Completed
Anti-Tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer
Last Updated: June 26, 2009
Condition(s): Breast Cancer
6
Not yet recruiting
A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
Last Updated: May 17, 2012
Condition(s): Hormone Receptor Positive Breast Cancer
7
Recruiting
Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Postmenopausal Women With Advanced Breast Cancer
Last Updated: March 26, 2012
Condition(s): Breast Cancer
8
Active, not recruiting
Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
Last Updated: April 17, 2012
Condition(s): Breast Cancer
9
Recruiting
Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women
Last Updated: July 26, 2011
Condition(s): Metastatic Breast Cancer; Estrogen Receptor Positive Tumor; Breast Cancer Nos Premenopausal
10
Not yet recruiting
AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer
Last Updated: May 10, 2012
Condition(s): Advanced Metastatic Breast Cancer
11
Not yet recruiting
Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
Last Updated: March 20, 2012
Condition(s): Breast Cancer
12
Active, not recruiting
Efficacy and Safety of 500mg of Fulvestrant as a First Line Hormonal Treatment in Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
Last Updated: June 2, 2011
Condition(s): Breast Cancer
13
Active, not recruiting
Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer
Last Updated: February 29, 2012
Condition(s): Breast Cancer
14
Not yet recruiting
BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer
Last Updated: October 14, 2011
Condition(s): Estrogen Receptor-positive Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
15
Active, not recruiting
Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
Last Updated: February 14, 2012
Condition(s): Breast Cancer
16
Completed
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
Last Updated: February 14, 2012
Condition(s): Advanced Breast Cancer; Metastatic Breast Cancer
17
Active, not recruiting
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
Last Updated: March 30, 2012
Condition(s): Locally Advanced Breast Cancer; Metastatic Breast Cancer
18
Recruiting
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Last Updated: October 21, 2011
Condition(s): Invasive Breast Cancer
19
Suspended
Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy
Last Updated: April 26, 2012
Condition(s): Breast Cancer
20
Recruiting
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
Last Updated: January 24, 2012
Condition(s): Breast Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=fulvestrant

Page 1 of Clinical Trials for fulvestrant, 98 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About